Paper Details
- Home
- Paper Details
Treatment of age-associated memory impairment with guanfacine.
Author: CoffeyD J, CrookT H, JenkynL R, LarrabeeG J, McEnteeW J, PetrieW
Original Abstract of the Article :
Alpha2 adrenergic agonists have been shown to improve memory test performance in amnesic humans and aged nonhuman primates. In a group of drugs in this class that were tested for their effects on age-related memory impairments in aged monkeys, guanfacine was the most effective for improving mnemonic...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/1862205
データ提供:米国国立医学図書館(NLM)
Treatment of Age-Associated Memory Impairment with Guanfacine
This study explores the potential of [guanfacine], an [alpha2 adrenergic agonist], for treating [age-associated memory impairment (AAMI)]. The researchers investigated the effects of guanfacine on learning and memory in individuals with AAMI. Their findings provide insights into the potential of this medication for improving cognitive function in older adults.
Guanfacine: A Potential Solution for Memory Impairment?
The study's results suggest that [guanfacine] may have [modest mood-improving effects] but did not show significant effects on [learning and memory] in individuals with [AAMI]. While these findings are preliminary, they highlight the need for further research to explore the potential of guanfacine and other alpha2 adrenergic agonists for treating AAMI.
Navigating the Challenges of Age-Related Cognitive Decline
Age-related cognitive decline is a common concern for older adults. This research underscores the importance of exploring new and effective treatments to maintain cognitive function and improve the quality of life for older adults. While the study's findings did not show significant effects of guanfacine on memory, they highlight the need for continued research into potential therapies for AAMI.
Dr. Camel's Conclusion
Age-associated memory impairment can feel like a desert of forgotten thoughts. This research explores the potential of [guanfacine] as a treatment for AAMI. While the results were inconclusive, it's a reminder that the quest for treatments for cognitive decline is a long and winding path. We must continue to search for solutions that can help older adults maintain their cognitive abilities and live fulfilling lives.
Date :
- Date Completed 1991-09-05
- Date Revised 2013-11-21
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.